How to perform competitor analysis for biotechs

Welcome, fellow spies, to the ultimate guide on how to spy on your rivals without getting caught! Kidding, of course. We all know that in the biotech world, competition can be as fierce as a pack of hungry lab rats fighting over the last piece of cheese. But fear not, for with the right tools and tricks, you can stay one step ahead of your competitors and be the unicorn that stands out from the crowd. So grab your pipettes, put on your lab coats, and let’s get ready to rumble in the petri dish of biotech rivalry! This article explores how to perfor  competitor analysis for biotechs. 

First of all: Is competitive analysis like spying on the competition?

No, conducting a competitive analysis or comparing the branding of two biotech companies is not the same as spying on the competition. However, competitive analysis is a common business practice involving gathering publicly available information about competitors to understand their strengths, weaknesses, and market position.

Competitive analysis is a legitimate and ethical business practice that can help companies make informed decisions about their product development, marketing, and pricing strategies. The goal is not to obtain confidential or proprietary information from competitors but to gain insights into the market landscape and industry trends.

Comparing the branding of two biotech companies is a similar practice that involves analyzing publicly available information about each company’s marketing and branding strategies to understand how they position themselves in the market and communicate their value proposition to potential customers and investors.

It’s important to note that there are ethical and legal boundaries when conducting competitive analysis. Companies should avoid any practices that could be construed as unethical or illegal, such as stealing trade secrets or violating intellectual property rights.

What are results of competitive research for biotech products?

Competitive research for biotech products can provide valuable insights into the market landscape and help companies make more informed decisions about product development, marketing, and pricing strategies. Here are some expected outcomes of competitive research for biotech products:

  1. Identification of direct and indirect competitors: Competitive research can help identify both direct and indirect competitors in the market, including products that may be used for similar indications or that use similar technology.
  2. Assessment of market trends and dynamics: By analyzing the competitive landscape, companies can gain a better understanding of market trends and dynamics, including changes in market size, competitive intensity, and pricing.
  3. Evaluation of product features and benefits: Competitive research can help companies understand how their product compares to similar products regarding features, benefits, and limitations. This can help guide product development and improve product differentiation.
  4. Pricing analysis: Competitive research can provide insights into how other companies are pricing their products and help companies develop competitive pricing strategies.
  5. Branding and marketing: Understanding the competitive landscape can help companies develop branding and marketing strategies that effectively differentiate their product and resonate with target customers.
  6. Partnership opportunities: Competitive research can identify potential partnership opportunities with other companies or research institutions that can help accelerate product development or increase market access.

Overall, competitive research is essential for biotech companies to stay ahead of the competition, identify market opportunities, and make informed decisions about product development and commercialization strategies.


How can you compare the branding of two biotech companies?

Comparing the branding of two biotech companies can help you understand how they are positioning themselves in the market and communicating their value proposition to potential customers and investors. Here are some key elements to consider when comparing the branding of two biotech companies:

  1. Mission and values: Review each company’s mission and values statements to understand their overall purpose and goals. Look for similarities and differences in positioning themselves and what they stand for.
  2. Visual identity: Review each company’s visual identity, including logo, colour palette, and overall design aesthetic. Consider how well their branding aligns with their mission and values and how memorable and distinctive their visual identity is.
  3. Messaging and positioning: Analyze the messaging and positioning used by each company in their marketing materials, website, and other communications. Look for similarities and differences in positioning their products or services, what benefits they emphasize, and what tone and language they use.
  4. Target audience: Consider each company’s target audience and whether their branding and messaging effectively resonate with this audience. Look for any specific demographic or psychographic profiles that each company is targeting and how well they are addressing these audiences’ needs and pain points.
  5. Brand reputation: Research each company’s reputation in the market, including how customers perceive them, investors, and other stakeholders. Look for any key strengths or weaknesses in their brand reputation and how this may impact their ability to attract customers or secure investment.
  6. Marketing channels: Consider each company’s marketing channels and how well they leverage each channel to reach their target audience. Look for unique or innovative marketing strategies each company uses and their effectiveness in driving awareness and engagement.

By comparing these essential elements, you can better understand how each biotech company positions itself in the market and how effectively its branding and messaging communicate its value proposition to potential customers and investors.

How can you run a proper competitive analysis for a biotech company?

Running a proper competitive analysis for a biotech company involves:

  • Gathering and analyzing data on competitors in the biotech industry.
  • Identifying their strengths and weaknesses.
  • Comparing them to your company’s strengths and weaknesses.

Here are some steps you can take to conduct a competitive analysis for a biotech company:

  1. Identify your competitors: List your company’s direct competitors, including those that produce similar products or services.
  2. Gather information on competitors: Collect information on your competitors’ products, services, research and development efforts, intellectual property, regulatory approvals, patents, and financial performance. This information can be obtained from industry reports, market research, company websites, regulatory filings, and news articles.
  3. Analyze competitors’ strengths and weaknesses: Evaluate your competitors’ strengths and weaknesses by assessing their market share, product differentiation, research and development capabilities, intellectual property portfolio, financial performance, and partnerships with other companies.
  4. Identify opportunities and threats: Based on your analysis of competitors’ strengths and weaknesses, identify opportunities and threats for your company. Opportunities might include gaps in the market that your company can fill or areas where it can differentiate itself from competitors. Threats might include new competitors entering the market or regulatory or legal requirements changes that could impact your business.
  5. Compare your company to competitors: Compare your company to competitors, assessing how well you stack up against them in terms of product quality, pricing, customer service, and other factors.
  6. Develop a strategy: Based on your analysis of competitors and your own company, develop a strategy to position your company for success in the biotech industry. This might include identifying areas where your company can differentiate itself from competitors, investing in research and development to stay ahead of the curve, or forming partnerships with other companies to enhance your capabilities.
  7. Monitor competitors: Finally, monitor your competitors continuously to stay up-to-date on their activities and adjust your strategy as needed. This might involve keeping an eye on news articles, regulatory filings, or industry reports and attending industry conferences and events.

What are common mistakes people make when performing competitive analysis for biotech?

Performing a competitive analysis for biotech products can be a complex process, and people can make several common mistakes. Here are some of the most common mistakes to avoid:

  1. Focusing too narrowly: One common mistake is focusing too narrowly on one aspect of the competition, such as analyzing product features or pricing. It’s essential to take a broader view and consider various factors, including market trends, customer needs, and the regulatory environment.
  2. Relying on outdated information: Biotech is a rapidly changing industry, and it’s vital to ensure that the information used for the analysis is up-to-date and accurate. Relying on outdated information can lead to inaccurate conclusions and missed opportunities.
  3. Overlooking indirect competitors: It’s easy to focus on direct competitors, but it’s also important to consider indirect competitors, such as products or services that may be used for similar indications or that use similar technology.
  4. Neglecting to validate assumptions: It’s crucial to validate assumptions and conclusions based on research data by testing them against real-world scenarios. Neglecting to do so can lead to inaccurate conclusions and missed opportunities.
  5. Overestimating market size or demand: Biotech products can take a long time to develop and reach the market, and it’s important to avoid overestimating the market size or demand for a product before it is fully developed or approved.
  6. Failing to consider global competition: Biotech is a global industry, and it’s important to consider competition in the domestic market and globally.

By avoiding these common mistakes, you can conduct a more comprehensive and accurate competitive analysis for biotech products and make more informed decisions about product development and commercialization strategies.



Specific questions:

Should you focus on the online or offline parts of a business?

The decision to focus on online or offline marketing efforts for a biotech company depends on several factors, including the company’s target audience, marketing goals, and available resources.


Biotech companies should generally have a robust online presence, as much of the industry’s research, development, and innovation is driven by technology and digital tools. Additionally, a significant portion of the target audience, such as researchers, clinicians, and investors, will likely be tech-savvy and spend much time online.


However, offline efforts should not be overlooked. In-person meetings, conferences, and networking events can provide valuable opportunities to connect with potential customers, partners, and investors. Trade shows and other industry events can also help to increase brand awareness and showcase products and services tangibly.


Ultimately, a comprehensive marketing strategy for a biotech company should include a mix of online and offline tactics tailored to the company’s specific goals and target audience. By understanding the preferences and behaviours of the target audience and leveraging both online and offline channels effectively, a biotech company can maximize its marketing impact and achieve its business objectives.


What are the aspects to differentiate yourself when looking for an investor?

You must differentiate yourself and your company from other potential investment opportunities when looking for an investor. Here are some aspects that can help differentiate yourself:

  1. Unique value proposition: Clearly articulate what sets your company apart from others in the industry. Please explain how your technology, product, or service is unique and why it has the potential to disrupt the market.
  2. Traction and growth potential: Demonstrate that your company has already gained some traction in the market and has the potential for significant growth. Share data on customer acquisition, revenue growth, and other key performance indicators.
  3. Strong team: Investors want to see a team with the expertise and experience to execute the company’s vision. Highlight the critical members of your team and their relevant experience.
  4. Intellectual property: This can be a valuable differentiator if your company has patents or other intellectual property. Highlight any unique patents, trade secrets, or other proprietary technology your company has developed.
  5. Industry partnerships and collaborations: If your company has established partnerships or collaborations with other companies or research institutions, this can demonstrate credibility and potential for future growth.
  6. Social impact: Many investors are interested in companies that are positively impacting society or the environment. If your company has a social or environmental mission, highlight this and explain how it aligns with the investor’s values.
  7. Financials: Investors want to see that your company has a clear path to profitability and a solid financial plan. Provide detailed financial projections, including revenue and expense forecasts, and explain how you plan to use investment funds to grow the company.

By effectively communicating these aspects, a biotech company can differentiate itself from other investment opportunities and increase the likelihood of securing funding from the right investor.


Is it harder to perform competitive analysis for a biotech product or a platform?

Performing competitive analysis for a biotech product or platform can be challenging, but some differences in the approach may make one more complicated than the other.

In the case of a biotech product, the competitive landscape is likely to focus on similar products that are directly competing. Therefore, the product can be evaluated based on efficacy, safety, cost, and ease of use. However, there may be limited direct competitors, and they may be easier to identify, analyze and compare.

In contrast, a biotech platform may be a more complex system that offers multiple functionalities or services. As a result, the competitive landscape can be broader. It may include other platforms or technologies that may not be directly comparable, making it harder to determine which platforms compete directly with yours. In addition, platform companies may have different business models or revenue streams, making it harder to compare them in financial metrics such as revenue or profit margins.

Furthermore, platforms often rely on partnerships and collaborations with other companies or institutions to deliver their services, which can add additional complexity when analyzing the competitive landscape.

Overall, performing competitive analysis for biotech products and platforms requires a deep understanding of the industry and the specific market niche the product or platform is targeting. However, the complexity of the technology and the competitive landscape can make it harder to perform a competitive analysis for biotech platforms compared to biotech products.

















Did you know we help build awesome brands?

We can either teach you how or get involved and create something exciting together. Start a conversation to receive a portfolio.

How To Define Your Target Audience in Pharma and Biotech

How To Define Your Target Audience in Pharma and Biotech

Understanding your target audience is crucial in the complex landscapes of pharmaceutical and biotechnology industries. Explore different strategies for three distinct groups: large pharmaceutical companies, mid-sized firms, and small biotech startups, ensuring successful engagements and long-term partnerships.

What is Biotech Business Development? 

What is Biotech Business Development? 

Explore the integral role of biotech business development in merging science with commerce, the broad scope of life sciences, the varied roles of its professionals, and the significance of strategic planning for market success.